Event Date
June 17-18, 2026
Venue
Berlin, Germany
– Previous Conference Performers / Professionals From Around The Globe –
Media Partners/Collaborator
A huge thanks to all our amazing partners. We couldn’t have a conference without you!










Sponsors/Exhibitors
A huge thanks to all our amazing partners. We couldn’t have a conference without you!


About the Conference
The 18th Edition of the International Conference on Diabetes and Endocrinology (ICDE 2026) invites researchers, clinicians, healthcare professionals, academicians, and industry leaders to gather in Berlin on June 17–18, 2026.
ICDE 2026 aims to provide a global platform for discussing cutting-edge research, innovative treatments, emerging technologies, and collaborative strategies in the fields of diabetes, endocrinology, and metabolic disorders.
With a legacy of successful annual meetings, ICDE 2026 continues its tradition of fostering scientific excellence, networking, and knowledge exchange among international experts.
ICDE 2026 will focus on:
- Advances in diabetes research and treatment
- Innovations in endocrinology and hormonal therapies
- Artificial intelligence and digital health in metabolic care
- Prevention strategies and global health policies
- Translational research and clinical applications
The event will feature:
- Keynote presentations by global experts
- Plenary talks
- Oral and poster sessions
- Industry exhibitions
- Panel discussions
- Networking forums
This conference will serve as a multidisciplinary hub bringing together academia, healthcare institutions, pharmaceutical companies, and biotech industries.
Who Should Attend?
ICDE 2026 is ideal for:
- Endocrinologists
- Diabetologists
- Physicians & Surgeons
- Clinical Researchers
- Medical Scientists
- Public Health Professionals
- Nutritionists & Dietitians
- Diabetes Educators
- Pharmaceutical & Biotech Professionals
- Medical Device Manufacturers
- Healthcare Policy Makers
- Academic Faculty & Students
- Research Scholars
🎯 Conference Benefits
Attendees will gain:
✅ Scientific Advancement
- Exposure to the latest research findings
- Access to unpublished data and clinical trial updates
- Insights into global best practices
✅ Networking Opportunities
- Meet world-renowned experts
- Connect with potential collaborators
- Establish partnerships with industry leaders
✅ Professional Development
- Present your research to an international audience
- Receive constructive feedback from experts
- Earn conference certification
✅ Business & Industry Exposure
- Discover emerging technologies
- Connect with pharmaceutical and device companies
- Explore investment and funding opportunities
Scientific Sessions & Tracks
- Advances in Diabetes Research
Latest discoveries in pathophysiology and molecular mechanisms.
- Type 1 Diabetes
Autoimmune mechanisms, genetics, and emerging therapies.
- Type 2 Diabetes
Insulin resistance, lifestyle management, and pharmacological treatments.
- Gestational Diabetes
Maternal-fetal health, screening protocols, and prevention.
- Pediatric Endocrinology
Growth disorders, juvenile diabetes, and hormonal imbalances.
- Obesity & Metabolic Syndrome
Epidemiology, prevention, and therapeutic interventions.
- Thyroid Disorders
Hyperthyroidism, hypothyroidism, thyroid cancer, and management strategies.
- Adrenal Disorders
Cushing’s syndrome, Addison’s disease, adrenal tumors.
- Pituitary Disorders
Acromegaly, prolactinomas, and hormonal regulation.
- Reproductive Endocrinology
PCOS, infertility, and hormonal therapies.
- Bone & Mineral Metabolism
Osteoporosis, calcium disorders, vitamin D deficiency.
- Diabetes Complications
Neuropathy, nephropathy, retinopathy, cardiovascular risks.
- Cardiometabolic Health
Hypertension, lipid disorders, integrated care approaches.
- Artificial Intelligence in Endocrinology
AI-driven diagnostics and predictive analytics.
- Digital Health & Wearables
Continuous glucose monitoring, remote patient care.
- Precision Medicine
Genomics and personalized treatment strategies.
- Clinical Trials & Drug Development
Novel therapeutics and regulatory updates.
- Nutrition & Lifestyle Interventions
Dietary management and exercise protocols.
- Public Health & Epidemiology
Global diabetes trends and prevention strategies.
- Future Innovations in Endocrinology
Biotechnology, regenerative medicine, and stem cell therapy.
Market Analysis
Global Diabetes Market
- The global diabetes market is projected to exceed USD 150 billion by 2030.
- Increasing prevalence of Type 2 diabetes due to sedentary lifestyles.
- Rising demand for insulin delivery systems and glucose monitoring devices.
- Growth in digital therapeutics and telemedicine.
Endocrinology Therapeutics Market
- Expansion in hormonal therapy drugs.
- Increasing adoption of AI-based diagnostic tools.
- Rapid growth in personalized medicine.
- Strong investment in biotech innovation.
Key Drivers
- Aging population
- Urbanization
- Rising obesity rates
- Technological innovation
- Government health initiatives
ICDE 2026 provides a critical platform for stakeholders to explore these growing opportunities.
Venue Information
Berlin – A Global Hub for Science & Innovation
Berlin is one of Europe’s leading centers for research, healthcare innovation, and international conferences. Known for its rich history, vibrant culture, and advanced infrastructure, Berlin provides an ideal setting for a global medical event.
Why Berlin?
- Excellent international connectivity
- World-class conference facilities
- Renowned medical research institutions
- Multicultural and welcoming environment
Attendees can explore iconic landmarks such as:
- Brandenburg Gate
- Berlin Wall Memorial
- Museum Island
Berlin combines professional excellence with cultural enrichment, making ICDE 2026 both scientifically rewarding and personally memorable.
– Tracks & Key Topics –
-
Diabetes
-
Diabetes mellitus
-
Type 1 diabetes
-
Type 2 diabetes
-
Gestational diabetes
-
Prediabetes
-
Hyperglycemia
-
Hypoglycemia
-
Insulin resistance
-
Insulin therapy
-
Blood glucose monitoring
-
Continuous glucose monitoring
-
Glycemic control
-
HbA1c
-
Diabetic complications
-
Diabetic neuropathy
-
Diabetic nephropathy
-
Diabetic retinopathy
-
Cardiovascular complications in diabetes
-
Metabolic syndrome
-
Obesity and diabetes
-
Pediatric diabetes
-
Adult-onset diabetes
-
Endocrine disorders
-
Pancreatic beta cells
-
Glucose metabolism
-
Lipid metabolism
-
Diabetes prevention
-
Diabetes management
-
Diabetes education
-
Lifestyle intervention
-
Medical nutrition therapy
-
Physical activity and diabetes
-
Oral antidiabetic drugs
-
Injectable diabetes medications
-
Insulin pumps
-
Closed-loop insulin systems
-
Precision medicine in diabetes
-
Personalized diabetes care
-
Digital diabetes management
-
Telemedicine for diabetes
-
Artificial intelligence in diabetes care
-
Diabetes clinical trials
-
Epidemiology of diabetes
-
Global diabetes burden
-
Diabetes screening
-
Early diagnosis of diabetes
-
Beta-cell dysfunction
-
Autoimmune diabetes
-
Latent autoimmune diabetes in adults (LADA)
-
Diabetic ketoacidosis
-
Hyperosmolar hyperglycemic state
-
Microvascular complications
-
Macrovascular complications
-
Diabetes and hypertension
-
Diabetes and dyslipidemia
-
Pregnancy and diabetes
-
Diabetes self-management
-
Nutrition and diabetes
-
Long-term diabetes outcomes










































